DJIA 17,689.86 -56.12 -0.32%
NASDAQ 5,128.28 -0.50 -0.01%
S&P 500 2,103.84 -4.79 -0.23%
market minute promo

GlaxoSmithKline (NYSE: GSK)



company name or ticker
Company Photos
(Click to zoom)

This Could Be Johnson & Johnson’s Future

As competition heats up for Johnson & Johnson's current blockbuster drugs like Zytiga and Remicade, we have to look into the pipeline to see what the future could hold.

Premarket Biotech Digest: Arrowhead Initiates Dosing, Vertex Orkambi Approval, Insider Sales

Week In Review: Zhongheng Pays $52 Million For Oramed's Diabetes Drugs

GlaxoSmithKline: An Undervalued 'Work In Progress'

Sector's Smaller Players Show The Way

PSA: Afrezza Is NOT Exubera

Premarket Biotech Digest: Gilead Files TAF NDA, Pristiq Goes Generic, Biocept Surges 7%

Premarket Biotech Digest: Celgene-Juno, AbbVie Rx Data, FDA-Gilead Lawsuit

Best 3 Yielding Buy-Rated Stocks: VLY, LHO, GSK

3 Reasons I Have Little Confidence in GlaxoSmithKline's Dividend

GlaxoSmithKline is yielding nearly 6% on a trailing 12-month basis, but these three factors have the potential to dramatically cut its payout in the coming years.
See More Articles...